Aerobic exercise training increases neuronal nitric oxide release and bioavailability and decreases noradrenaline release in mesenteric artery from spontaneously hypertensive rats. 2013

Javier Blanco-Rivero, and Fernanda R Roque, and Esther Sastre, and Laura Caracuel, and Gisele K Couto, and María Soledad Avendaño, and Suliana M Paula, and Luciana V Rossoni, and Mercedes Salaices, and Gloria Balfagón
Departamento de Fisiología, Facultad de Medicina, Universidad Autónoma de Madrid, Spain.

OBJECTIVE To study the effect of aerobic exercise training on sympathetic, nitrergic and sensory innervation function in superior mesenteric artery from spontaneously hypertensive rats (SHRs). METHODS De-endothelized vascular rings from sedentary and trained SHRs (treadmill 12 weeks) were used. Vasomotor responses to electrical field stimulation (EFS), noradrenaline, nitric oxide donor DEA-NO and calcitonin gene-related peptide (CGRP) were studied. Neuronal nitric oxide synthase (nNOS) expression and nitric oxide, superoxide anions (O(2.-)), noradrenaline and CGRP levels were also determined. RESULTS Aerobic exercise training decreased vasoconstrictor response to EFS but increased noradrenaline response. Phentolamine decreased while N(ω)-nitro-(L)-arginine methyl ester ((L)-NAME) increased the response to EFS; the effect of both drugs was greater in trained animals. Training also decreased noradrenaline release and O(2.-) production and increased nNOS expression, nitric oxide release and the vasodilator response to DEA-NO. The O(2.-) scavenger tempol increased DEA-NO-induced vasodilation only in sedentary rats. The EFS-induced contraction was increased to a similar extent in both experimental groups by preincubation with CGRP (8-37). CGRP release and vasodilator response were not modified by training. CONCLUSIONS Aerobic exercise training decreases contractile response to EFS in mesenteric artery from SHRs. This effect is the net result of decreased noradrenaline release, increased sensitivity to the vasoconstrictive effects of noradrenaline and increased neuronal nitric oxide release and bioavailability. These modifications might contribute to the beneficial effects of aerobic exercise training on blood pressure.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008638 Mesenteric Arteries Arteries which arise from the abdominal aorta and distribute to most of the intestines. Arteries, Mesenteric,Artery, Mesenteric,Mesenteric Artery
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D009638 Norepinephrine Precursor of epinephrine that is secreted by the ADRENAL MEDULLA and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers, and of the diffuse projection system in the brain that arises from the LOCUS CERULEUS. It is also found in plants and is used pharmacologically as a sympathomimetic. Levarterenol,Levonorepinephrine,Noradrenaline,Arterenol,Levonor,Levophed,Levophed Bitartrate,Noradrenaline Bitartrate,Noradrénaline tartrate renaudin,Norepinephrin d-Tartrate (1:1),Norepinephrine Bitartrate,Norepinephrine Hydrochloride,Norepinephrine Hydrochloride, (+)-Isomer,Norepinephrine Hydrochloride, (+,-)-Isomer,Norepinephrine d-Tartrate (1:1),Norepinephrine l-Tartrate (1:1),Norepinephrine l-Tartrate (1:1), (+,-)-Isomer,Norepinephrine l-Tartrate (1:1), Monohydrate,Norepinephrine l-Tartrate (1:1), Monohydrate, (+)-Isomer,Norepinephrine l-Tartrate (1:2),Norepinephrine l-Tartrate, (+)-Isomer,Norepinephrine, (+)-Isomer,Norepinephrine, (+,-)-Isomer
D010805 Physical Conditioning, Animal Diet modification and physical exercise to improve the ability of animals to perform physical activities. Animal Physical Conditioning,Animal Physical Conditionings,Conditioning, Animal Physical,Conditionings, Animal Physical,Physical Conditionings, Animal
D011918 Rats, Inbred SHR A strain of Rattus norvegicus with elevated blood pressure used as a model for studying hypertension and stroke. Rats, Spontaneously Hypertensive,Rats, SHR,Inbred SHR Rat,Inbred SHR Rats,Rat, Inbred SHR,Rat, SHR,Rat, Spontaneously Hypertensive,SHR Rat,SHR Rat, Inbred,SHR Rats,SHR Rats, Inbred,Spontaneously Hypertensive Rat,Spontaneously Hypertensive Rats
D004558 Electric Stimulation Use of electric potential or currents to elicit biological responses. Stimulation, Electric,Electrical Stimulation,Electric Stimulations,Electrical Stimulations,Stimulation, Electrical,Stimulations, Electric,Stimulations, Electrical
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001682 Biological Availability The extent to which the active ingredient of a drug dosage form becomes available at the site of drug action or in a biological medium believed to reflect accessibility to a site of action. Availability Equivalency,Bioavailability,Physiologic Availability,Availability, Biologic,Availability, Biological,Availability, Physiologic,Biologic Availability,Availabilities, Biologic,Availabilities, Biological,Availabilities, Physiologic,Availability Equivalencies,Bioavailabilities,Biologic Availabilities,Biological Availabilities,Equivalencies, Availability,Equivalency, Availability,Physiologic Availabilities

Related Publications

Javier Blanco-Rivero, and Fernanda R Roque, and Esther Sastre, and Laura Caracuel, and Gisele K Couto, and María Soledad Avendaño, and Suliana M Paula, and Luciana V Rossoni, and Mercedes Salaices, and Gloria Balfagón
December 2004, European journal of pharmacology,
Javier Blanco-Rivero, and Fernanda R Roque, and Esther Sastre, and Laura Caracuel, and Gisele K Couto, and María Soledad Avendaño, and Suliana M Paula, and Luciana V Rossoni, and Mercedes Salaices, and Gloria Balfagón
January 2003, Journal of vascular research,
Javier Blanco-Rivero, and Fernanda R Roque, and Esther Sastre, and Laura Caracuel, and Gisele K Couto, and María Soledad Avendaño, and Suliana M Paula, and Luciana V Rossoni, and Mercedes Salaices, and Gloria Balfagón
January 1996, Journal of biomedical science,
Javier Blanco-Rivero, and Fernanda R Roque, and Esther Sastre, and Laura Caracuel, and Gisele K Couto, and María Soledad Avendaño, and Suliana M Paula, and Luciana V Rossoni, and Mercedes Salaices, and Gloria Balfagón
March 2022, Antioxidants (Basel, Switzerland),
Javier Blanco-Rivero, and Fernanda R Roque, and Esther Sastre, and Laura Caracuel, and Gisele K Couto, and María Soledad Avendaño, and Suliana M Paula, and Luciana V Rossoni, and Mercedes Salaices, and Gloria Balfagón
January 2006, Neuroendocrinology,
Javier Blanco-Rivero, and Fernanda R Roque, and Esther Sastre, and Laura Caracuel, and Gisele K Couto, and María Soledad Avendaño, and Suliana M Paula, and Luciana V Rossoni, and Mercedes Salaices, and Gloria Balfagón
May 2004, Journal of hypertension,
Javier Blanco-Rivero, and Fernanda R Roque, and Esther Sastre, and Laura Caracuel, and Gisele K Couto, and María Soledad Avendaño, and Suliana M Paula, and Luciana V Rossoni, and Mercedes Salaices, and Gloria Balfagón
August 2009, Clinical science (London, England : 1979),
Javier Blanco-Rivero, and Fernanda R Roque, and Esther Sastre, and Laura Caracuel, and Gisele K Couto, and María Soledad Avendaño, and Suliana M Paula, and Luciana V Rossoni, and Mercedes Salaices, and Gloria Balfagón
June 2004, Journal of applied physiology (Bethesda, Md. : 1985),
Javier Blanco-Rivero, and Fernanda R Roque, and Esther Sastre, and Laura Caracuel, and Gisele K Couto, and María Soledad Avendaño, and Suliana M Paula, and Luciana V Rossoni, and Mercedes Salaices, and Gloria Balfagón
February 2002, Journal of hypertension,
Javier Blanco-Rivero, and Fernanda R Roque, and Esther Sastre, and Laura Caracuel, and Gisele K Couto, and María Soledad Avendaño, and Suliana M Paula, and Luciana V Rossoni, and Mercedes Salaices, and Gloria Balfagón
September 2015, Journal of hypertension,
Copied contents to your clipboard!